Market Newsdesk

RAANANA, ISRAEL, April 08, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced the closing of its previously announced registered direct offering and concurrent private placement with a single institutional investor. The Company issued Ordinary Shares and pre-funded warrants in a registered direct offering. In a concurrent private placement, the Company also issued to the same investor pre-funded and investor warrants. Aggregate gross proceeds to the Company from both transactions were approximately $3.5 million. The transactions closed on April 8, 2026.

The transactions consisted of the sale of 388,888 Units (or Pre-Funded Units), each consisting of one (1) Ordinary Share (or one (1) Pre-Funded Warrant to purchase one (1) Ordinary Share) and one (1) Common Warrant to purchase one (1) Ordinary Share, at a combined offering price of $9.00 per Unit (or $8.99999 per Pre-Funded Unit, equal to the offering price per Unit minus an exercise price of $0.00001 per Pre-Funded Warrant). In the registered direct offering, the Company sold 87,777 Ordinary Shares and 190,000 Pre-Funded Warrants. In the concurrent private placement, the Company also sold 111,111 PIPE Pre-Funded Warrants and 388,888 PIPE Common Warrants. The Common Warrants have an exercise price of $9.00 per share. The Pre-Funded Warrants are immediately exercisable (subject to registration for unregistered PIPE Pre-Funded Warrants) and may be exercised at any time until exercised in full. For each Pre-Funded Warrant sold in lieu of an Ordinary Share, the number of Ordinary Shares offered was decreased on a one-for-one basis.

The Company expects to use the net proceeds from the offerings, together with its existing cash, for general corporate purposes and working capital. Following completion of the offering, the Company will have 2,083,939 Ordinary Shares issued and outstanding, assuming the exercise of all Pre-Funded Warrants and PIPE Pre-Funded Warrants issued in the offering.

Aegis Capital Corp. acted as exclusive placement agent for the offerings.
Greenberg Traurig, P.A. acted as U.S. counsel to the Company and Meitar | Law Offices acted as Israeli counsel to the Company. Kaufman & Canoles, P.C. acted as U.S. counsel to Aegis Capital Corp.

The registered direct offering was made pursuant to an effective shelf registration statement on Form F-3 (No. 333-291368) previously filed with the U.S. Securities and Exchange Commission (SEC) and declared effective by the SEC on December 3, 2025. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC’s website located at www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Aegis Capital Corp., Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at [email protected], or by telephone at +1 (212) 813-1010.

The offer and sale of the securities in the private placement were made in a transaction not involving a public offering and have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or applicable state securities laws. Accordingly, the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. The securities were offered only to accredited investors. Pursuant to a registration rights agreement with the investors, the Company has agreed to file one or more registration statements with the SEC covering the resale of the Ordinary Shares and the Shares issuable upon exercise of the pre-funded warrants and warrants.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Polyrizon Ltd.

Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Polyrizon’s proprietary Capture and Contain TM, or C&C, hydrogel technology, comprised of a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a “biological mask” with a thin shield containment barrier in the nasal cavity. Polyrizon is further developing certain aspects of its C&C hydrogel technology such as the bioadhesion and prolonged retention at the nasal deposition site for intranasal delivery of drugs. Polyrizon refers to its additional technology, which is in an earlier stage of pre-clinical development, that is focused on nasal delivery of active pharmaceutical ingredients, or APIs, as Trap and Target ™, or T&T. For more information, please visit https://polyrizon-biotech.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the timing and completion of the offering, the satisfaction of customary closing conditions related to the offering and the intended use of proceeds therefrom. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s annual report filed with the SEC on March 25, 2026 and subsequent filings with the SEC. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Polyrizon is not responsible for the contents of third-party websites.

Michal Efraty
Investor Relations
[email protected]

ISSAQUAH, Wash., April 08, 2026 (GLOBE NEWSWIRE) — Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $28.41 billion for the retail month of March, the five weeks ended April 5, 2026, an increase of 11.3 percent from $25.51 billion last year.

Net sales for the first 31 weeks were $173.26 billion, an increase of 9.1 percent from $158.87 billion last year.

Comparable sales for the periods ended April 5, 2026, were as follows:

	5 Weeks		31 Weeks
U.S.	8.7%		6.3%
Canada	10.7%		8.8%
Other International	11.9%		10.9%
Total Company	9.4%		7.2%
Digitally-Enabled	23.3%		22.0%

Comparable sales excluding the impacts from changes in gasoline prices and foreign exchange were as follows:

	5 Weeks		31 Weeks
U.S.	6.2%		6.1%
Canada	5.4%		7.8%
Other International	6.6%		6.6%
Total Company	6.2%		6.4%
Digitally-Enabled	22.5%		21.5%

March had one less shopping day versus last year, due to the calendar shift of Easter. This negatively impacted both total and comparable sales by approximately one and one-half percent.

Additional discussion of these results is available in a pre-recorded message. It can be accessed by visiting investor.costco.com (click on “Events & Presentations”). This message will be available through 4:00 p.m. (PT) on Wednesday, April 15, 2026.
        
Costco currently operates 928 warehouses, including 637 in the United States and Puerto Rico, 115 in Canada, 42 in Mexico, 37 in Japan, 29 in the United Kingdom, 20 in Korea, 15 in Australia, 14 in Taiwan, seven in China, five in Spain, three in France, two in Sweden, and one each in Iceland, and New Zealand. Costco also operates e-commerce sites in the U.S., Canada, the U.K., Mexico, Korea, Taiwan, Japan and Australia.

Certain statements contained in this document and the pre-recorded message constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. For these purposes, forward-looking statements are statements that address activities, events, conditions or developments that the Company expects or anticipates may occur in the future. In some cases forward-looking statements can be identified because they contain words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “likely,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will,” “would,” or similar expressions and the negatives of those terms. Such forward-looking statements involve risks and uncertainties that may cause actual events, results or performance to differ materially from those indicated by such statements. These risks and uncertainties include, but are not limited to, domestic and international economic conditions, including exchange rates, inflation or deflation, the effects of competition and regulation, uncertainties in the financial markets, consumer and small business spending patterns and debt levels, breaches of security or privacy of member or business information, conditions affecting the acquisition, development, ownership or use of real estate, capital spending, actions of vendors, rising costs associated with employees (generally including health-care costs and wages), workforce interruptions, energy and certain commodities, geopolitical conditions (including tariffs and global conflicts), the ability to maintain effective internal control over financial reporting, regulatory and other impacts related to environmental and social matters, public-health related factors, and other risks identified from time to time in the Company’s public statements and reports filed with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and the Company does not undertake to update these statements, except as required by law. Comparable sales and comparable sales excluding impacts from changes in gasoline prices and foreign exchange are intended as supplemental information and are not a substitute for net sales presented in accordance with U.S. GAAP.

CONTACTS:	Costco Wholesale Corporation
	Josh Dahmen, 425/313-8254
	Andrew Yoon, 425/313-6305

COST-Sales

SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) — QuantumScape Corporation (NASDAQ: QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced it will release its 2026 first-quarter business results after market close on Wednesday, April 22, 2026. This will be followed by a conference call at 2 p.m. Pacific Time (5 p.m. Eastern Time). Siva Sivaram, chief executive officer, and Kevin Hettrich, chief financial officer, will participate on the call.

Starting today, April 8, shareholders can submit questions (here) they would like addressed on the call. QuantumScape management will respond to a selection of the submitted questions. The company will accept questions until Tuesday, April 21, at 2 p.m. Pacific Time (5 p.m. Eastern Time).

The call will be accessible live via a webcast on QuantumScape’s IR Events Calendar page. An archive of the webcast will be available shortly after the call for 12 months.

About QuantumScape Corporation

QuantumScape is on a mission to revolutionize energy storage to enable a sustainable future. The company’s next-generation batteries are designed to enable greater energy density, faster charging and enhanced safety to support the transition away from legacy energy sources toward a lower carbon future. For more information, visit www.quantumscape.com.

Contacts:

For Investors

[email protected]

For Media

[email protected]

ZestyAI’s 

Z-FIRE

wildfire risk model will support property-level rating and underwriting as Kingstone enters the California homeowners market on an E&S basis

KINGSTON, N.Y., April 08, 2026 (GLOBE NEWSWIRE) — Kingstone Companies, Inc. (Nasdaq: KINS) (the “Company” or “Kingstone”), a property and casualty insurance holding company, today announced a partnership with ZestyAI to deploy property-level wildfire risk analytics as part of Kingstone’s planned expansion into the California homeowners market. As previously disclosed, Kingstone will enter California in Q2 2026 on an excess and surplus lines (E&S) basis, applying the same disciplined, data-driven underwriting approach that has driven record financial results in New York.

As part of its California rating and underwriting framework, Kingstone has integrated ZestyAI’s Z-FIRE™ wildfire risk model among the tools used to evaluate wildfire exposure at the individual-property level and to support disciplined underwriting in catastrophe-exposed regions.

Z-FIRE uses machine learning to evaluate each property’s unique characteristics, including defensible space, building materials, topography, and vegetation, to assess wildfire exposure at a granular level. This property-level insight enables Kingstone to differentiate risk within the same territory, improving rating and underwriting precision and portfolio oversight.

“Our California entry reflects the same disciplined, data-driven approach that has driven our results in New York,” said Sarah (Minlei) Chen, SVP, Chief Actuary and Head of Product Management. “ZestyAI’s Z-FIRE model complements our Select platform by providing the property-level wildfire intelligence we need to rate and underwrite with precision in a complex and dynamic market like California.”

“Wildfire risk is pushing the insurance industry to embrace more advanced analytics and AI-driven decision making,” said Attila Toth, Founder and CEO of ZestyAI. “With a clearer understanding of risk, insurers can make confident decisions about where they grow, how they manage exposure, and how they continue serving communities in wildfire-prone regions.”

Z-FIRE is used by carriers across Western wildfire states and was the first AI-based wildfire model included in an approved carrier rate filing in California.

Kingstone’s California strategy builds on the operational and underwriting transformation the Company has executed over the past four years. The Company’s E&S structure provides pricing flexibility to apply forward-looking wildfire models, set rates to achieve target margin requirements, and maintain strict underwriting standards including real-time accumulation management. Kingstone is maintaining a 30% quota share on its California business to manage net exposure during the initial scaling period.

About Kingstone Companies, Inc.

Kingstone is a Northeast regional property and casualty insurance holding company whose principal operating subsidiary is Kingstone Insurance Company (“KICO”). KICO is a New York domiciled carrier writing business through retail and wholesale agents and brokers. Kingstone delivers tailored homeowners insurance solutions through its sophisticated product suite, Select, supported by a scalable and efficient operating platform that enables the Company to pursue significant market opportunities and strategic expansion. KICO was the 11th largest writer of homeowners insurance in New York in 2025 and is also licensed in New Jersey, Rhode Island, Massachusetts, Connecticut, Pennsylvania, New Hampshire, and Maine.

Kingstone Investor Relations Contact:

Elevate IR
[email protected]
720-330-2829

About ZestyAI

ZestyAI is the Risk and Decision Intelligence Platform for the insurance industry. Trusted by Property & Casualty carriers, reinsurers, brokers, and regulators across the United States, ZestyAI helps insurers make better decisions faster and with greater confidence. The platform unifies property-level data, predictive AI models, and agentic AI automation to transform how insurers see, price, and manage risk. Through machine learning, computer vision, and regulatory-grade transparency, ZestyAI delivers precision and performance across underwriting, rating, reinsurance, and regulatory workflows.

Validated by climate science and historical loss data, ZestyAI’s models cover major perils including wildfire, severe convective storm, and non-weather water. From improving pricing accuracy to strengthening reinsurance outcomes, ZestyAI brings trusted AI to every insurance decision—helping the industry operate with speed, accuracy, and resilience.

Forward-Looking Statements

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, may be forward-looking statements. These statements are based on management’s current expectations and are subject to uncertainty and changes in circumstances. These statements involve risks and uncertainties that could cause actual results to differ materially from those included in forward-looking statements due to a variety of factors. For more details on factors that could affect expectations, see Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025.

The risks and uncertainties include, without limitation, the following:

• the risk of significant losses from catastrophes and severe weather events;
• risks related to the lack of a financial strength rating from A.M. Best;
• risks related to limitations on the ability of our insurance subsidiary to pay dividends to us;
• adverse capital, credit and financial market conditions;
• risks related to volatility in net investment income;
• the unavailability of reinsurance at current levels and prices;
• the exposure to greater net insurance losses in the event of reduced reliance on reinsurance;
• the credit risk of our reinsurers;
• the inability to maintain the requisite amount of risk-based capital needed to grow our business;
• the effects of climate change on the frequency or severity of weather events and wildfires;
• risks related to the limited market area of our business;
• risks related to a concentration of business in a limited number of producers;
• legislative and regulatory changes, including changes in insurance laws and regulations and their application by our regulators;  
• the effects of competition in our market areas;
• our reliance on certain key personnel;
• risks related to security breaches or other attacks involving our computer systems or those of our vendors;
• our reliance on information technology and information systems; and
• risks related to our diversification and growth strategy, including with regard to the California market.

Kingstone undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Third-Quarter Net Income of $0.9 million, or $0.07 per diluted share

Q3 FY26 net sales increase led by a 9.7% YoY increase in
PMT net sales

Total backlog at February 28, 2026, was up 11.4% from end of the fiscal second quarter

LAFOX, Ill., April 08, 2026 (GLOBE NEWSWIRE) — Richardson Electronics, Ltd. (NASDAQ: RELL) today reported financial results for its third quarter ended February 28, 2026. The Company also announced that its Board of Directors declared a $0.06 per share quarterly cash dividend.

“I am pleased to report that Richardson Electronics has now delivered seven consecutive quarters of year-over-year sales growth, reflecting continued progress in executing our multi-year strategy. Our performance this quarter was led by strong momentum in PMT, particularly in EDG and the semifab equipment market. Third quarter sales growth was supported by continued discipline around gross margin and operating expenses. Our performance reflects the strength of our team, as we continue to invest across the organization to build depth, technical expertise, and operating performance,” said Edward J. Richardson, Chairman, CEO, and President.

“As we look ahead, our backlog now stands at its highest level in nearly three years, providing us with confidence in our future growth outlook. We are seeing sustained demand across key end markets, particularly in power management, energy transition, and semiconductor applications, and we believe our focused investments in engineering, product development, and customer engagement are positioning us to capitalize on these opportunities. With a strengthened pipeline, strong balance sheet, and improving order trends, we remain confident in our ability to drive continued growth and deliver long-term value for our shareholders,” Mr. Richardson concluded. 

Third Quarter Results

Net sales for the third quarter of fiscal 2026 were $55.5 million, a 3.1% increase from $53.8 million in the prior year’s third quarter. When excluding Healthcare, net sales increased 6.0% year-over-year.

 Year-over-year net sales growth was due to higher sales in PMT. PMT sales increased due to strong growth in semi-conductor wafer fab and RF and Microwave products. Since the January 2025 Healthcare asset sale, the Healthcare segment was consolidated into the PMT segment. When excluding Healthcare net sales, PMT net sales increased by 14.5%. GES sales decreased by $0.5 million, or 5.4% due to project timing. Canvys’ sales decreased $1.2 million, or 13.5%, due to project timing in North America.

 Backlog grew 11.4% to $151.2 million at the end of the third quarter of fiscal 2026, versus $135.7 million at the end of the second quarter of fiscal 2026, primarily driven by an increase in PMT. While total GES backlog improved slightly, core backlog grew more, highlighting continued strength in underlying demand for both new products and existing programs.

 Gross margin for the third quarter was 31.9% of net sales, compared to 31.0% during the third quarter of fiscal 2025. PMT gross margin increased to 32.1%, compared to 29.9%, as a result of product mix and lower manufacturing under absorption. GES gross margin decreased to 30.8%, from 32.8% due to product mix. Canvys gross margin decreased to 32.2%, from 33.2% primarily due to unfavorable manufacturing absorption and higher freight costs.

Operating expenses were $16.2 million, compared to $14.5 million in the third quarter of fiscal 2025. The increase in operating expenses resulted from higher salaries and incentives associated with critical adds to staff and in support of our existing employees, as well as related medical benefits and travel expenses. Also, the operating expenses in the third quarter of fiscal 2025 were historically low.

Operating income was $1.5 million for the third quarter of fiscal 2026, compared to an operating loss of $2.7 million and non-GAAP operating income* of $2.2 million in the prior year’s third quarter. Other expenses for the third quarter of fiscal 2026, including interest income and foreign exchange were $0.3 million, compared to other expenses of $0.3 million in the third quarter of fiscal 2025.

Income tax provision was $0.3 million for the third quarter of fiscal 2026, versus an income tax benefit of $1.0 million and non-GAAP income tax provision* of $0.2 million in the prior year’s third quarter. The effective tax rate for the third quarter of fiscal 2026 was 25.3%.

Net income was $0.9 million for the third quarter of fiscal 2026, compared to net loss of $2.1 million and non-GAAP net income* of $1.6 million for the third quarter of fiscal 2025. Earnings per common share (diluted) were $0.07 in the third quarter of fiscal 2026, compared to net loss per common share (diluted) of $0.15 and non-GAAP earnings per common share (diluted)* of $0.11 in the third quarter of fiscal 2025.

EBITDA* was $2.2 million in the third quarter of fiscal 2026. EBITDA* for the third quarter of fiscal 2025 was a negative $2.1 million. EBITDA* after adjusting to exclude the loss on the sale of the majority of Healthcare assets (Adjusted EBITDA*) was $2.8 million in the third quarter of fiscal 2025.

The Company maintained its solid financial position with cash and cash equivalents of $29.5 million as of February 28, 2026, versus $33.1 million as of November 29, 2025. Cash used during the third quarter of fiscal 2026 primarily related to inventory associated with final buys from a critical supplier and the payment of dividends. The Company also invested $0.8 million during the quarter in capital expenditures, primarily related to its manufacturing business, facilities improvements, and IT systems, versus $0.5 million during last year’s third quarter.

As of the end of the third quarter of fiscal 2026, the Company had no outstanding debt on its revolving line of credit with PNC Bank.
Financial Summary for the Nine Months Ended February 28, 2026

• Net sales for the first nine months of fiscal 2026 were $162.4 million, an increase of 3.4%, compared to net sales of $157.0 million during the first nine months of fiscal 2025. When excluding Healthcare, net sales increased 7.2% year-over-year. Sales increased by $3.0 million or 2.8% for PMT, $1.0 million or 4.3% for GES and $1.3 million or 5.6% for Canvys. When excluding Healthcare net sales, PMT net sales increased 8.2%.
• Gross profit increased to $50.7 million during the first nine months of fiscal 2026, compared to $48.4 million during the first nine months of fiscal 2025. As a percentage of net sales, gross margin improved to 31.2% of net sales during the first nine months of fiscal 2026, compared to 30.8% during the first nine months of fiscal 2025.
• Operating expenses increased to $48.1 million for the first nine months of fiscal 2026, compared to $46.6 million for the first nine months of fiscal 2025. As a percentage of net sales, operating expenses were 29.6% in the first nine months of fiscal 2026 versus 29.7% in the prior year’s first nine months. The increase in operating expenses resulted primarily from higher salaries, incentive and legal expenses.
• Operating income during the first nine months of fiscal 2026 was $2.6 million, compared to an operating loss of $3.1 million and non-GAAP operating income* of $1.8 million during the first nine months of fiscal 2025.
• Other income, for the first nine months of fiscal 2026, including interest income, foreign exchange, and other, was $0.7 million, as compared to other expense of $0.4 million in the first nine months of fiscal 2025. The increase from the prior year’s first nine months was mainly due to a non-recurring gain of $0.9 million.
• The income tax provision was $0.6 million for the first nine months of fiscal 2026 compared to an income tax benefit of $1.3 million and non-GAAP income tax provision* of $1,000 during the first nine months of fiscal 2025.
• Net income for the first nine months of fiscal 2026 was $2.7 million, versus a net loss of $2.2 million and non-GAAP net income* of $1.4 million during the first nine months of fiscal 2025. Earnings per common share (diluted) were $0.19 for the first nine months of fiscal 2026 compared to $0.16 net loss per common share (diluted) and non-GAAP earnings per common share* of $0.10 for the first nine months of fiscal 2025.
• EBITDA* for the first nine months of fiscal 2026 was $6.2 million versus negative $0.5 million in the prior year’s first nine months. EBITDA* after adjusting to exclude the loss on the sale of Healthcare assets (Adjusted EBITDA*) was $4.5 million in the first nine months of fiscal 2025.

* Please refer to Unaudited Reconciliation between GAAP and non-GAAP Financial Measures below for a reconciliation of non-GAAP items to the comparable GAAP measures.

CASH DIVIDEND DECLARED

The Board of Directors of Richardson Electronics declared a $0.06 quarterly cash dividend per share to holders of common stock and a $0.054 cash dividend per share to holders of Class B common stock. The dividend will be payable on May 27, 2026, to common stockholders of record as of May 8, 2026.

NON-GAAP FINANCIAL MEASURES

In addition to financial measures (“GAAP financial measures”) prepared in accordance with generally accepted accounting principles in the United States (“GAAP”), we have included financial measures in this press release that are not defined by or calculated in accordance with GAAP (collectively, “non-GAAP financial measures”). For each of the non-GAAP financial measures referenced in this release, we are providing below a reconciliation of differences between the non-GAAP financial measure and the most directly comparable GAAP financial measure. We also provide an explanation of why the Company believes these non-GAAP financial measures provide useful information to investors, and any additional material purposes for which our management or Board of Directors use these non-GAAP financial measures.

Non-GAAP Operating Income: Non-GAAP operating income is GAAP operating income (loss), adjusted to exclude a one-time loss on the sale of assets of the Company’s Healthcare business recorded in fiscal 2025. The following table represents the Company’s calculation of non-GAAP operating income for the periods presented and a reconciliation to the most directly comparable GAAP financial measure:

	Unaudited
	($ in thousands)
	Three Months Ended								Nine Months Ended
	February 28, 2026				March 1, 2025				February 28, 2026				March 1, 2025
Operating income (loss) reconciliation
Income (loss) from operations	$	1,497			$	(2,743	)		$	2,597			$	(3,094	)
Loss on disposal of healthcare assets and other charges		—				4,916				—				4,916
Non-GAAP operating income	$	1,497			$	2,173			$	2,597			$	1,822

Non-GAAP Income Before Taxes: Non-GAAP Income Before Taxes is income (loss) before taxes, adjusted to exclude a one-time loss on the sale of assets of the Company’s Healthcare business recorded in fiscal 2025.The following table represents the Company’s calculation of non-GAAP Income Before Taxes for the periods presented and a reconciliation to the most directly comparable GAAP financial measure:

	Unaudited
	($ in thousands)
	Three Months Ended								Nine Months Ended
	February 28, 2026				March 1, 2025				February 28, 2026				March 1, 2025
Income (loss) before income taxes reconciliation
Income (loss) before income taxes	$	1,195			$	(3,088	)		$	3,329			$	(3,495	)
Loss on disposal of healthcare assets and other charges		—				4,916				—				4,916
Non-GAAP income before taxes	$	1,195			$	1,828			$	3,329			$	1,421

NON-GAAP FINANCIAL MEASURES



(continued)

Non-GAAP Income Tax Expense or Benefit: Non-GAAP Income Tax Expense or Benefit is income tax provision (benefit), adjusted to exclude a one-time loss on the sale of assets of the Company’s Healthcare business recorded in fiscal 2025. The following table represents the Company’s calculation of non-GAAP Income Tax Expense (Benefit) for the periods presented and a reconciliation to the most directly comparable GAAP financial measure:

	Unaudited
	($ in thousands)
	Three Months Ended								Nine Months Ended
	February 28, 2026				March 1, 2025				February 28, 2026				March 1, 2025
Income tax provision (benefit) reconciliation
Income tax provision (benefit)	$	302			$	(1,031	)		$	648			$	(1,277	)
Loss on disposal of healthcare assets and other charges		—				1,278				—				1,278
Non-GAAP income tax provision	$	302			$	247			$	648			$	1

        
Non-GAAP Net Income: Non-GAAP Net Income is net income (loss), adjusted to exclude a one-time loss on the sale of assets of the Company’s Healthcare business recorded in fiscal 2025. The following table represents the Company’s calculation of non-GAAP Net Income for the periods presented and a reconciliation to the most directly comparable GAAP financial measure:

	Unaudited
	($ in thousands)
	Three Months Ended								Nine Months Ended
	February 28, 2026				March 1, 2025				February 28, 2026				March 1, 2025
Net income (loss) reconciliation
Net income (loss)	$	893			$	(2,057	)		$	2,681			$	(2,218	)
Loss on disposal of healthcare assets and other charges		—				3,638				—				3,638
Non-GAAP net income	$	893			$	1,581			$	2,681			$	1,420

Non-GAAP Earnings Per Common Share (Diluted): Non-GAAP Earnings Per Common Share (Diluted) is net income (loss) per share (diluted), adjusted to exclude a one-time loss on the sale of assets of the Company’s Healthcare business recorded in fiscal 2025. The following table represents the Company’s calculation of non-GAAP Earnings Per Common Share (diluted) for the periods presented and a reconciliation to the most directly comparable GAAP financial measure:

	Unaudited
	Three Months Ended								Nine Months Ended
	February 28, 2026				March 1, 2025				February 28, 2026				March 1, 2025
Net income (loss) per share (diluted) reconciliation
Net income (loss) per share (diluted)	$	0.07			$	(0.15	)		$	0.19			$	(0.16	)
Loss on disposal of healthcare assets and other charges		—				0.26				—				0.26
Non-GAAP net income per share (diluted)	$	0.07			$	0.11			$	0.19			$	0.10

NON-GAAP FINANCIAL MEASURES



(continued)

EBITDA: EBITDA is net income (loss), plus income tax expense (benefit) and depreciation and amortization expense. The following table represents the Company’s calculation of EBITDA for the periods presented and a reconciliation to the most directly comparable GAAP financial measure:

	Unaudited
	($ in thousands)
	Three Months Ended								Nine Months Ended
	February 28, 2026				March 1, 2025				February 28, 2026				March 1, 2025
Net income (loss)	$	893			$	(2,057	)		$	2,681			$	(2,218	)
Income tax provision (benefit)		302				(1,031	)			648				(1,277	)
Depreciation & amortization		989				978				2,897				3,037
EBITDA	$	2,184			$	(2,110	)		$	6,226			$	(458	)

Adjusted EBITDA: Adjusted EBITDA is EBITDA (a non-GAAP financial measure defined and calculated in accordance with the above), adjusted to exclude a one-time loss on the sale of assets of the Company’s Healthcare business recorded in fiscal 2025. The following table represents the Company’s calculation of Adjusted EBITDA for the periods presented and a reconciliation to the most directly comparable GAAP financial measure:

	Unaudited
	($ in thousands)
	Three Months Ended								Nine Months Ended
	February 28, 2026				March 1, 2025				February 28, 2026				March 1, 2025
Net income (loss)	$	893			$	(2,057	)		$	2,681			$	(2,218	)
Income tax provision (benefit)		302				(1,031	)			648				(1,277	)
Depreciation & amortization		989				978				2,897				3,037
EBITDA		2,184				(2,110	)			6,226				(458	)
Loss on disposal of healthcare assets and other charges		–				4,916				–				4,916
Adjusted EBITDA	$	2,184			$	2,806			$	6,226			$	4,458

Management believes the non-GAAP financial measures referenced herein provide useful information to investors in assessing the Company’s financial performance because items that are not considered by the Company to be indicative of the Company’s ongoing results, such as the one-time loss on the sale of assets of the Company’s Healthcare business, are excluded.

Our management uses these non-GAAP financial measures along with the most directly comparable GAAP financial measures in evaluating our financial performance and when planning, forecasting and analyzing future periods. 

The non-GAAP financial measures presented herein, as determined and presented by the Company, may not be comparable to related or similarly titled measures reported by other companies. These non-GAAP financial measures are not intended to be used as a substitute for the related GAAP financial measures. The non-GAAP financial measures should be viewed in addition to, and not as an alternative for, our reported results prepared in accordance with GAAP.

CONFERENCE CALL INFORMATION

The Company will host a conference call and question-and-answer session on Thursday, April 9, 2026, at 9:00 a.m. Central Time, to discuss its third quarter fiscal 2026 results. 

Participants may register for the call here. While not required, it is recommended you join 10 minutes prior to the event start. A replay of the call will be available beginning at 1:00 p.m. Central Time on April 9, 2026, for seven days. Registration instructions are also on our website at www.rell.com.

In addition, the webcast link is available here.

FORWARD-LOOKING STATEMENTS

This release includes certain “forward-looking” statements as defined by the Securities and Exchange Commission. Statements in this press release regarding the Company’s business that are not historical facts represent “forward-looking” statements that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Item 1A, “Risk Factors” in the Company’s Annual Report on Form 10-K filed on August 4, 2025, and other reports we file with the Securities and Exchange Commission. The Company assumes no responsibility to update the “forward-looking” statements in this release as a result of new information, future events or otherwise.

ABOUT RICHARDSON ELECTRONICS, LTD.

Richardson Electronics, Ltd. is a leading global manufacturer of engineered solutions, green energy products, power grid and microwave tubes, and related consumables; power conversion and RF and microwave components including green energy solutions; tubes for diagnostic imaging equipment; and customized display solutions.

More than 55% of our products are manufactured in LaFox, Illinois, Marlborough, Massachusetts, or Donaueschingen, Germany, or by one of our manufacturing partners throughout the world. All our partners manufacture to our strict specifications and per our Supplier Code of Conduct. We serve customers in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The Company’s strategy is to provide specialized technical expertise and “engineered solutions” based on our core engineering and manufacturing capabilities. The Company provides solutions and adds value through design-in support, systems integration, prototype design and manufacturing, testing, logistics, and aftermarket technical service and repair through its global infrastructure. More information is available at www.rell.com.

Richardson Electronics’ common stock trades on the NASDAQ Global Select Market under the ticker symbol RELL. 

Richardson Electronics, Ltd. Consolidated Balance Sheets (in thousands, except per share amounts)
	Unaudited				Audited
	February 28, 2026				May 31, 2025
Assets
Current assets:
Cash and cash equivalents	$	29,494			$	35,901
Accounts receivable, less allowance for credit losses of $300 and $250, respectively		27,041				24,117
Inventories, net		107,619				102,799
Prepaid expenses and other assets		5,827				3,070
Total current assets		169,981				165,887
Non-current assets:
Property, plant and equipment, net		18,894				18,355
Intangible assets, net		300				345
Right of use lease assets, net		1,573				2,276
Deferred income tax assets		8,709				8,744
Other non-current assets		342				228
Total non-current assets		29,818				29,948
Total assets	$	199,799			$	195,835
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	23,010			$	21,339
Accrued liabilities		13,872				14,276
Lease liabilities current		938				1,171
Total current liabilities		37,820				36,786
Non-current liabilities:
Deferred income tax liabilities		84				81
Lease liabilities non-current		635				1,105
Other non-current liabilities		1,110				1,204
Total non-current liabilities		1,829				2,390
Total liabilities		39,649				39,176
Commitments and contingencies
Stockholders’ Equity
Common stock, $0.05 par value; 12,520 and 12,362 shares issued and outstanding on February 28, 2026 and May 31, 2025, respectively		625				618
Class B common stock, convertible, $0.05 par value; 2,037 and 2,049 shares issued and outstanding on February 28, 2026 and May 31, 2025, respectively		102				102
Additional paid-in-capital		76,088				74,445
Retained earnings		79,446				79,340
Accumulated other comprehensive income		3,889				2,154
Total stockholders’ equity		160,150				156,659
Total liabilities and stockholders’ equity	$	199,799			$	195,835

Richardson Electronics, Ltd. Unaudited Consolidated Statements of Comprehensive Income (Loss) (in thousands, except per share amounts)
	Three Months Ended								Nine Months Ended
	February 28, 2026				March 1, 2025				February 28, 2026				March 1, 2025
Net sales	$	55,472			$	53,804			$	162,367			$	157,020
Cost of sales		37,792				37,131				111,681				108,595
Gross profit		17,680				16,673				50,686				48,425
Selling, general and administrative expenses		16,176				14,500				48,079				46,607
Loss (gain) on disposal of property, plant and equipment		7				—				10				(4	)
Loss on disposal of healthcare assets and related charges		—				4,916				—				4,916
Operating income (loss)		1,497				(2,743	)			2,597				(3,094	)
Other (expense) income:
Interest income		122				84				436				187
Foreign exchange loss		(437	)			(456	)			(627	)			(616	)
Other, net		13				27				923				28
Total other (expense) income		(302	)			(345	)			732				(401	)
Income (loss) before income taxes		1,195				(3,088	)			3,329				(3,495	)
Income tax provision (benefit)		302				(1,031	)			648				(1,277	)
Net income (loss)		893				(2,057	)			2,681				(2,218	)
Foreign currency translation gain (loss), net of tax		1,072				(702	)			1,735				(1,814	)
Comprehensive income (loss)	$	1,965			$	(2,759	)		$	4,416			$	(4,032	)
Net income (loss) per share:
Common stock – Basic	$	0.07			$	(0.15	)		$	0.19			$	(0.16	)
Class B common stock – Basic		0.06				(0.13	)			0.17				(0.14	)
Common stock – Diluted		0.07				(0.15	)			0.19				(0.16	)
Class B common stock – Diluted		0.06				(0.13	)			0.17				(0.14	)
Weighted average number of shares:
Common stock – Basic		12,493				12,333				12,455				12,283
Class B common stock – Basic		2,037				2,049				2,044				2,049
Common stock – Diluted		12,696				12,333				12,628				12,283
Class B common stock – Diluted		2,037				2,049				2,044				2,049

Richardson Electronics, Ltd. Unaudited Consolidated Statements of Cash Flows (in thousands)
	Three Months Ended								Nine Months Ended
	February 28, 2026				March 1, 2025				February 28, 2026				March 1, 2025
Operating activities:
Net income (loss)	$	893			$	(2,057	)		$	2,681			$	(2,218	)
Adjustments to reconcile net income to cash (used in) provided by operating activities:
Unrealized foreign currency loss (gain)		(257	)			456				(421	)			429
Depreciation and amortization		989				978				2,897				3,037
Inventory provisions		135				123				314				346
Share-based compensation expense		330				320				1,296				1,226
Loss (gain) on disposal of property, plant and equipment		7				—				10				(4	)
Deferred income taxes		—				(3	)			36				(82	)
Loss on disposal of healthcare assets and related charges		—				4,916				—				4,916
Change in assets and liabilities:
Accounts receivable		642				(333	)			(2,532	)			(1,470	)
Inventories		(1,506	)			2,873				(2,999	)			1,132
Prepaid expenses and other assets		46				(382	)			(2,875	)			(344	)
Accounts payable		(682	)			2,585				1,406				7,249
Accrued liabilities		(2,924	)			(4,661	)			(563	)			(4,115	)
Other		(323	)			(214	)			(632	)			376
Net cash (used in) provided by operating activities		(2,650	)			4,601				(1,382	)			10,478
Investing activities:
Capital expenditures		(759	)			(549	)			(3,390	)			(1,992	)
Proceeds from sale of property, plant and equipment		—				—				—				7
Proceeds from disposal of Healthcare assets		—				6,985				—				6,985
Net cash (used in) provided by investing activities		(759	)			6,436				(3,390	)			5,000
Financing activities:
Proceeds from issuance of common stock		239				—				453				307
Cash dividends paid on common and Class B common stock		(859	)			(852	)			(2,575	)			(2,555	)
Proceeds from revolving credit facility		—				—				—				1,000
Repayment of revolving credit facility		—				—				—				(1,000	)
Other		—				—				(99	)			(159	)
Net cash used in by financing activities		(620	)			(852	)			(2,221	)			(2,407	)
Effect of exchange rate changes on cash and cash equivalents		385				(145	)			586				(659	)
(Decrease) increase in cash and cash equivalents		(3,644	)			10,040				(6,407	)			12,412
Cash and cash equivalents at beginning of period		33,138				26,635				35,901				24,263
Cash and cash equivalents at end of period	$	29,494			$	36,675			$	29,494			$	36,675

Richardson Electronics, Ltd.

Unaudited Net Sales and Gross Profit

For the Third Quarter and First Nine Months of Fiscal 2026 and 2025

($ in thousands)

By Strategic Business Unit

Net Sales

	Three Months Ended								FY26 vs. FY25
	February 28, 2026				March 1, 2025				% Change
PMT	$	38,726			$	35,310			9.7	%
GES		8,795				9,299			-5.4	%
Canvys		7,951				9,195			-13.5	%
Total	$	55,472			$	53,804			3.1	%

	Nine Months Ended								FY26 vs. FY25
	February 28, 2026				March 1, 2025				% Change
PMT	$	113,003			$	109,977			2.8	%
GES		24,359				23,359			4.3	%
Canvys		25,005				23,684			5.6	%
Total	$	162,367			$	157,020			3.4	%

Gross Profit

	Three Months Ended
	February 28, 2026				% of Net Sales			March 1, 2025				% of Net Sales
PMT	$	12,412			32.1	%		$	10,568			29.9	%
GES		2,711			30.8	%			3,049			32.8	%
Canvys		2,557			32.2	%			3,056			33.2	%
Total	$	17,680			31.9	%		$	16,673			31.0	%

	Nine Months Ended
	February 28, 2026				% of Net Sales			March 1, 2025				% of Net Sales
PMT	$	35,336			31.3	%		$	33,240			30.2	%
GES		7,375			30.3	%			7,337			31.4	%
Canvys		7,975			31.9	%			7,848			33.1	%
Total	$	50,686			31.2	%		$	48,425			30.8	%

Richardson Electronics, Ltd. Unaudited Reconciliation Between GAAP and Non-GAAP Financial Measures For the Third Quarter and First Nine Months of Fiscal 2026 and 2025 ($ in thousands)
NON-GAAP INCOME (LOSS)
	Three Months Ended								Nine Months Ended
	February 28, 2026				March 1, 2025				February 28, 2026				March 1, 2025
Operating income (loss) reconciliation
Income (loss) from operations	$	1,497			$	(2,743	)		$	2,597			$	(3,094	)
Loss on disposal of healthcare assets and other charges		—				4,916				—				4,916
Non-GAAP operating income	$	1,497			$	2,173			$	2,597			$	1,822
Income (loss) before income taxes reconciliation
Income (loss) before income taxes	$	1,195			$	(3,088	)		$	3,329			$	(3,495	)
Loss on disposal of healthcare assets and other charges		—				4,916				—				4,916
Non-GAAP income before taxes	$	1,195			$	1,828			$	3,329			$	1,421
Income tax provision (benefit) reconciliation
Income tax provision (benefit)	$	302			$	(1,031	)		$	648			$	(1,277	)
Loss on disposal of healthcare assets and other charges		—				1,278				—				1,278
Non-GAAP income tax provision	$	302			$	247			$	648			$	1
Net income (loss) reconciliation
Net income (loss)	$	893			$	(2,057	)		$	2,681			$	(2,218	)
Loss on disposal of healthcare assets and other charges		—				3,638				—				3,638
Non-GAAP net income	$	893			$	1,581			$	2,681			$	1,420
Net income (loss) per share (diluted) reconciliation
Net income (loss) per share (diluted)	$	0.07			$	(0.15	)		$	0.19			$	(0.16	)
Loss on disposal of healthcare assets and other charges		—				0.26				—				0.26
Non-GAAP net income per share (diluted)	$	0.07			$	0.11			$	0.19			$	0.10
EBITDA
	Three Months Ended								Nine Months Ended
	February 28, 2026				March 1, 2025				February 28, 2026				March 1, 2025
Net income (loss)	$	893			$	(2,057	)		$	2,681			$	(2,218	)
Income tax provision (benefit)		302				(1,031	)			648				(1,277	)
Depreciation & amortization		989				978				2,897				3,037
EBITDA		2,184				(2,110	)			6,226				(458	)
Loss on disposal of healthcare assets and other charges		—				4,916				—				4,916
Adjusted EBITDA	$	2,184			$	2,806			$	6,226			$	4,458

For Details Contact:		40W267 Keslinger Road
Edward J. Richardson	Robert J. Ben	PO BOX 393
Chairman and CEO	EVP & CFO	LaFox, IL 60147-0393 USA
Phone: (630) 208-2320	(630) 208-2203	(630) 208-2200 | Fax: (630) 208-2550

HOUSTON, April 08, 2026 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced that its Board of Trustees has declared a quarterly cash dividend of $0.1425 per share on the Company’s common shares and operating partnership units for the second quarter of 2026.  

The second quarter dividend distribution for 2026 will be as detailed below:

Month	Record Date	Payment Date	Distribution per Share/Unit
June	6/17/2026	6/29/2026	$0.1425

About Whitestone REIT

Whitestone REIT (NYSE: WSR) is a community-centered real estate investment trust (REIT) that acquires, owns, operates, and develops open-air, retail centers located in some of the fastest growing markets in the country:  Phoenix, Austin, Dallas-Fort Worth, Houston and San Antonio. 

Our centers are convenience focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education and entertainment to the surrounding communities. The Company believes its strong community connections and deep tenant relationships are key to the success of its current centers and its acquisition strategy. For additional information, please visit the Company’s investor relations website.

Forward-Looking Statements

This Report contains forward-looking statements within the meaning of the federal securities laws, including discussion and analysis of our financial condition, pending acquisitions and the impact of such acquisitions on our financial condition and results of operations, anticipated capital expenditures required to complete projects, amounts of anticipated cash distributions to our shareholders in the future and other matters. These forward-looking statements are not historical facts but are the intent, belief or current expectations of our management based on its knowledge and understanding of our business and industry. Forward-looking statements are typically identified by the use of terms such as “may,” “will,” “should,” “potential,” “predicts,” “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates” or the negative of such terms and variations of these words and similar expressions, although not all forward-looking statements include these words. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control, are difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.

Factors that could cause actual results to differ materially from any forward-looking statements made in this Report include: the imposition of federal income taxes if we fail to qualify as a real estate investment trust (“REIT”) in any taxable year or forego an opportunity to ensure REIT status; uncertainties related to the national economy, the real estate industry in general and in our specific markets; legislative or regulatory changes, including changes to laws governing REITs; adverse economic or real estate developments or conditions in Texas or Arizona, Houston and Phoenix in particular, including the potential impact of COVID-19 on our tenants’ ability to pay their rent, which could result in bad debt allowances or straight-line rent reserve adjustments; inflation and increases in interest rates, operating costs or general and administrative expenses; availability and terms of capital and financing, both to fund our operations and to refinance our indebtedness as it matures; decreases in rental rates or increases in vacancy rates; litigation risks; lease-up risks, including leasing risks arising from exclusivity and consent provisions in leases with significant tenants; our inability to renew tenant leases or obtain new tenant leases upon the expiration of existing leases; our inability to generate sufficient cash flows due to market conditions, competition, uninsured losses, changes in tax or other applicable laws; geopolitical conflicts, such as the ongoing conflict between Russia and Ukraine; the need to fund tenant improvements or other capital expenditures out of operating cash flow; and the risk that we are unable to raise capital for working capital, acquisitions or other uses on attractive terms or at all and other factors detailed in the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other documents the Company files with the Securities and Exchange Commission from time to time.

Investor and Media Contact:

David Mordy
Director of Investor Relations
Whitestone REIT
(713) 435-2219
[email protected]